Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-02-25

Clinical Trial Update: The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression

View source ↗

Summary

A completed clinical trial investigated the role of the aromatic hydrocarbon receptor in neuroblastoma tumorigenesis and its relationship with MYCN expression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Neuroblastoma | Status: COMPLETED